ENDLOS-TURBO PUT - BIOGEN IDEC | Delayed Deutsche Boerse AG 13:04:50 04/06/2024 BST | ||
| 10.81 EUR | +1.89% |
|
| Current month | -5.35% | ||
| 1 month | -11.14% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 04/06/24 | 10.81 | +1.89% |
| 03/06/24 | 10.61 | -5.35% |
| 31/05/24 | 11.21 | -3.94% |
| 30/05/24 | 11.67 | -3.55% |
| 29/05/24 | 12.1 | +2.63% |
Delayed Quote Deutsche Boerse AG
Last update June 04, 2024 at 01:04 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DW6DR9 |
| ISIN | DE000DW6DR94 |
| Date issued | 04/10/2022 |
| Strike | 343.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 7.15 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.61 € |
|---|---|
| Lowest since issue | 1.66 € |
| Spread | 0.06 € |
| Spread % | 0.55% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
229.8
USD
Average target price
284.8
USD
Spread / Average Target
+23.93%
- Stock Market
- Certificates
- Certificat